Medical Properties Trust (MPT) stock
Members see every stock ranked and every check behind each score, live.
What moves REITs
Why MPT scores 0
Below AverageTrending down, 0 of 14 checks firingWhat the Quality Score means
- 0Momentum traits 0 of 14 firing right now, one point each
- 0Long-term trend 165 sessions listed, no 200-day yet
What's next
Expected to report Thu Oct 29, before the open
After its last 3 reports it closed -1.1% on average, higher 1 of 3 times.
What would turn MPT's score around: 5 things, for members
Here is what members see.
Every stock gets a card like this one, and a page with its price in real time, every line of its score, the chart, and its filings.





Nothing is firing on MPT right now
One per group is shown here.
How MPT ranks in Reit
MPT is #89 of 129 by Quality Score. The top three are shown with their scores, and the rest by name.
LTC6/1415
DRH7/1413
WELL1/1412
HHHOpen for its score
PEBOpen for its score
MPT0/140
When does MPT report, and what happens after?
Expected to report Thu Oct 29, before the open (in 30 days). Not yet confirmed by the company.
| Reported | When | Gap | Reaction | 5 sessions |
|---|---|---|---|---|
| Aug 10, 2026Before open | Before open | -4.3% | -11.7% | -11.1% |
| Apr 30, 2026Before open | Before open | +0.6% | -3.7% | +1.9% |
| Feb 19, 2026Before open | Before open | +8.0% | +12.1% | +7.3% |
Who is trading MPT
Insiders
One insider bought $10K across 1 filing in the last 6 months. No open-market sales on record. The newest:
Congress and the White House
One trade disclosed in the last six months. The newest:
About Medical Properties Trust
Medical Properties Trust Inc acquires and develops net-leased healthcare facilities. Its investments in healthcare real estate, other loans, and any investments in tenants are considered a single reportable segment. Its business strategy is to acquire and develop healthcare facilities and lease the facilities to healthcare operating companies under long-term net leases, which require the tenant to bear of the costs associated with the property. The group's geographic areas are the United States, the United Kingdom, and All other countries.
Every line of the score, on every stock.
- Real-time prices, no delay
- Every line of MPT's score, with the points and the reason
- All 14 checks on MPT and on all 2,950 stocks
- Every stock ranked, with the chart
- Every filing, and optional alerts on MPT
Straight answers.
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Members, trial included, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Where does the data come from?
Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week traits rest on real history. Options flow is not part of the product.
What does it cost?
Nothing for the first 8 days. After that, one plan with everything in it, only if you choose to subscribe: $29 a month, $69 for three months, or $249 a year. Payments go through Stripe, so Breakaway never sees your card.
Is this investment advice?
No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.